1. |
Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng, 2001, 7(2): 211-228.
|
2. |
Gimble JM, Bunnell BA, Guilak F. Human adipose-derived cells: an update on the transition to clinical translation. Regen Med, 2012, 7(2): 225-235.
|
3. |
Gimble JM, Bunnell BA, Chiu ES, et al. Concise review: Adipose-derived stromal vascular fraction cells and stem cells: let’s not get lost in translation. Stem Cells, 2011, 29(5): 749-754.
|
4. |
Sensebé L, Bourin P, Tarte K. Good manufacturing practices production of mesenchymal stem/stromal cells. Hum Gene Ther, 2011, 22(1): 19-26.
|
5. |
Lin K, Matsubara Y, Masuda Y, et al. Characterization of adipose tissue-derived cells isolated with the Celution system. Cytotherapy, 2008, 10(4): 417-426.
|
6. |
Güven S, Karagianni M, Schwalbe M, et al. Validation of an automated procedure to isolate human adipose tissue-derived cells by using the Sepax? technology. Tissue Eng Part C Methods, 2012. [Epub ahead of print].
|
7. |
黃海玲, 劉宏偉, 佘文莉, 等. 介紹一種微創無菌快速獲取可移植脂肪顆粒裝置. 中華整形外科雜志, 2011, 27(6): 467-468.
|
8. |
Doi K, Tanaka S, Iida H, et al. Stromal vascular fraction isolated from lipo-aspirates using an automated processing system: bench and bed analysis. J Tissue Eng Regen Med, 2012. [Epub ahead of print].
|
9. |
Yoshimura K, Shigeura T, Matsumoto D, et al. Characterization of freshly isolated and cultured cells derived from the fatty and fluid portion of liposuction aspirates. J Cell Physiol, 2006, 208(1): 64-76.
|
10. |
Lindroos B, Aho KL, Kuokkanen H, et al. Differential gene expression in adipose stem cells cultured in allogeneic human serum versus fetal bovine serum. Tissue Eng Part A, 2010, 16(7): 2281-2294.
|
11. |
王太平, 徐國彤, 周琪, 等. 國際干細胞研究學會《干細胞臨床轉化指南》. 生命科學, 2009, 21(5): 747-756.
|
12. |
Fink T, Rasmussen JG, Lund P, et al. Isolation and expansion of adipose-derived stem cells for tissue engineering. Front Biosci (Elite Ed), 2011, 3: 256-263.
|
13. |
van Harmelen V, Skurk T, Röhrig K, et al. Effect of BMI and age on adipose tissue cellularity and differentiation capacity in women. Int J Obes Relat Metab Disord, 2003, 27(8): 889-895.
|
14. |
Mojallal A, Lequeux C, Shipkov C, et al. Influence of age and body mass index on the yield and proliferation capacity of adipose-derived stem cells. Aesthetic Plast Surg, 2011, 35(6): 1097-1105.
|
15. |
Ogawa R, Mizuno H, Watanabe A, et al. Adipogenic differentiation by adipose-derived stem cells harvested from GFP transgenic mice-including relationship of sex differences. Biochem Biophys Res Commun, 2004, 319(2): 511-517.
|
16. |
Aksu AE, Rubin JP, Dudas JR, et al. Role of gender and anatomical region on induction of osteogenic differentiation of human adipose-derived stem cells. Ann Plast Surg, 2008, 60(3): 306-322.
|
17. |
Chen HT, Lee MJ, Chen CH, et al. Proliferation and differentiation potential of human adipose-derived mesenchymal stem cells isolated from elderly patients with osteoporotic fractures. J Cell Mol Med, 2012, 16(3): 582-593.
|
18. |
Shu W, Shu YT, Yundai C, et al. Comparing the biological characteristics of adipose tissue-derived stem cells of different persons. J Cell Biochem, 2012, 113(6): 2020-2026.
|
19. |
Alt EU, Senst C, Murthy SN, et al. Aging alters tissue resident mesenchymal stem cell properties. Stem Cell Res, 2012, 8(2): 215-225.
|
20. |
Sowa Y, Imura T, Numajiri T, et al. Adipose-derived stem cells produce factors enhancing peripheral nerve regeneration: influence of age and anatomic site of origin. Stem Cells Dev, 2012, 21(11): 1852-1862.
|
21. |
陳燕, 陸志剛, 白海, 等. 細胞內外海藻糖對紅細胞冰凍干燥保存的影響. 中國輸血雜志, 2012, 25(3): 236-239.
|
22. |
劉廣鵬, 李宇琳, 孫劍, 等. 低溫凍存對人脂肪來源干細胞成骨能力影響的實驗研究. 中國修復重建外科雜志, 2010, 24(10): 1224-1227.
|
23. |
Feng Z, Ting J, Alfonso Z, et al. Fresh and cryopreserved, uncultured adipose tissue-derived stem and regenerative cells ameliorate ischemia-reperfusion-induced acute kidney injury. Nephrol Dial Transplant, 2010, 25(12): 3874-3884.
|
24. |
Lee JE, Kim I, Kim M. Adipogenic differentiation of human adipose tissue-derived stem cells obtained from cryopreserved adipose aspirates. Dermatol Surg, 2010, 36(7): 1078-1083.
|
25. |
Martinello T, Bronzini I, Maccatrozzo L, et al. Canine adipose-derived-mesenchymal stem cells do not lose stem features after a long-term cryopreservation. Res Vet Sci, 2011, 91(1): 18-24.
|
26. |
James AW, Levi B, Nelson ER, et al. Deleterious effects of freezing on osteogenic differentiation of human adipose-derived stromal cells in vitro and in vivo. Stem Cells Dev, 2011, 20(3): 427-439.
|
27. |
Matsumoto D, Shigeura T, Sato K, et al. Influences of preservation at various temperatures on liposuction aspirates. Plast Reconstr Surg, 2007, 120(6): 1510-1517.
|
28. |
Prockop DJ, Brenner M, Fibbe WE, et al. Defining the risks of mesenchymal stromal cell therapy. Cytotherapy, 2010, 12(5): 576-578.
|
29. |
Ra JC, Kang SK, Shin IS, et al. Stem cell treatment for patients with autoimmune disease by systemic infusion of culture-expanded autologous adipose tissue derived mesenchymal stem cells. J Transl Med, 2011, 9: 181.
|
30. |
López-Iglesias P, Blázquez-Martínez A, Fernández-Delgado J, et al. Short and long term fate of human AMSC subcutaneously injected in mice. World J Stem Cells, 2011, 3(6): 53-62.
|
31. |
Sun B, Roh KH, Park JR, et al. Therapeutic potential of mesenchymal stromal cells in a mouse breast cancer metastasis model. Cytotherapy, 2009, 11(3): 289-298.
|
32. |
Pinilla S, Alt E, Abdul Khalek FJ, et al. Tissue resident stem cells produce CCL5 under the influence of cancer cells and thereby promote breast cancer cell invasion. Cancer Lett, 2009, 284(1): 80-85.
|
33. |
Zimmerlin L, Donnenberg AD, Rubin JP, et al. Regenerative therapy and cancer: in vitro and in vivo studies of the interaction between adipose-derived stem cells and breast cancer cells from clinical isolates. Tissue Eng Part A, 2011, 17(1-2): 93-106.
|
34. |
Muehlberg FL, Song YH, Krohn A, et al. Tissue-resident stem cells promote breast cancer growth and metastasis. Carcinogenesis, 2009, 30(4): 589-597.
|
35. |
Donnenberg VS, Zimmerlin L, Rubin JP, et al. Regenerative therapy after cancer: what are the risks? Tissue Eng Part B Rev, 2010, 16(6): 567-575.
|